Becton, Dickinson and Company BDX Medical — Segment Operating Income as a Percent of Revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Becton, Dickinson and Company in its filing.
Tagged under the XBRL concept bdx:SegmentOperatingIncomeLossAsAPercentOfRevenues.
The official record: Becton, Dickinson and Company’s 10-K, filed November 25, 2025, on SEC EDGAR. View the filing →
Ask your AI about Becton, Dickinson and Company's medical — segment operating income as a percent of revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Becton, Dickinson and Company's medical — segment operating income as a percent of revenues?
- Becton, Dickinson and Company (BDX) reported medical — segment operating income as a percent of revenues of 9% in Q3 2025.
- How has Becton, Dickinson and Company's medical — segment operating income as a percent of revenues changed year-over-year?
- Becton, Dickinson and Company's medical — segment operating income as a percent of revenues increased by 1.4% year-over-year, from 8.9% to 9%.
- What is the long-term trend for Becton, Dickinson and Company's medical — segment operating income as a percent of revenues?
- Over 2 years (2023 to 2025), Becton, Dickinson and Company's medical — segment operating income as a percent of revenues has grown at a 1.1% compound annual growth rate (CAGR), from 35.3% to 36.1%.
- What does medical — segment operating income as a percent of revenues mean?
- This metric represents the operating profitability of the medical segment relative to its total revenue. It measures how effectively the segment manages its cost of goods sold and operating expenses to generate profit from its core medical product lines.